Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
  Home Print this page Email this page Small font sizeDefault font sizeIncrease font size Users Online: 815  
Year : 2016  |  Volume : 15  |  Issue : 2  |  Page : 114-123

A 3D Monte Carlo method for estimation of patient-specific internal organs absorbed dose for 99m Tc-hynic-Tyr 3 -octreotide imaging

1 Department of Medical Physics, Faculty of Medicine, University of Medical Sciences, Mashhad, Iran
2 Department of Medical Physics, Medical Physics Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
3 Department of Nuclear Medicine, Nuclear Medicine Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
4 Department of Medical Physics, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

Correspondence Address:
Ruhollah Ghahraman Asl
Department of Medical Physics, Faculty of Medicine, Mashhad University of Medical Sciences, Pardis -e Daneshgah, Vakil Abad Blvd., Mashhad
Login to access the Email id

DOI: 10.4103/1450-1147.174700

PMID: 27134562

Rights and Permissions

Single-photon emission computed tomography (SPECT)-based tracers are easily available and more widely used than positron emission tomography (PET)-based tracers, and SPECT imaging still remains the most prevalent nuclear medicine imaging modality worldwide. The aim of this study is to implement an image-based Monte Carlo method for patient-specific three-dimensional (3D) absorbed dose calculation in patients after injection of 99m Tc-hydrazinonicotinamide (hynic)-Tyr 3 -octreotide as a SPECT radiotracer. 99m Tc patient-specific S values and the absorbed doses were calculated with GATE code for each source-target organ pair in four patients who were imaged for suspected neuroendocrine tumors. Each patient underwent multiple whole-body planar scans as well as SPECT imaging over a period of 1-24 h after intravenous injection of 99m hynic-Tyr 3 -octreotide. The patient-specific S values calculated by GATE Monte Carlo code and the corresponding S values obtained by MIRDOSE program differed within 4.3% on an average for self-irradiation, and differed within 69.6% on an average for cross-irradiation. However, the agreement between total organ doses calculated by GATE code and MIRDOSE program for all patients was reasonably well (percentage difference was about 4.6% on an average). Normal and tumor absorbed doses calculated with GATE were slightly higher than those calculated with MIRDOSE program. The average ratio of GATE absorbed doses to MIRDOSE was 1.07 ± 0.11 (ranging from 0.94 to 1.36). According to the results, it is proposed that when cross-organ irradiation is dominant, a comprehensive approach such as GATE Monte Carlo dosimetry be used since it provides more reliable dosimetric results.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded345    
    Comments [Add]    
    Cited by others 8    

Recommend this journal